KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Esto marca un cambio importante desde que Estados Unidos eliminara el sarampión en el año 2000. Hasta ahora, el virus aparecía de manera esporádica, con personas infectadas en el extranjero, pero rara vez provocaba brotes locales debido a las altas tasas de vacunación.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Two Trump administration regulatory rollbacks affect nursing home staffing and home care workers, and a new AI experiment in Medicare has alarmed eldercare advocates and congressional Democrats.
With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents — and they’re frustrated that the Trump administration isn’t doing more to limit its use.
Lawmakers appear on the brink of passing a spending bill for the Department of Health and Human Services and a bipartisan health policy bill delayed for over a year. But the outlook is bleaker for the health care outline released by President Trump last week. Sandhya Raman of CQ Roll Call, Sheryl Gay Stolberg of The New York Times, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews oncologist and bioethicist Ezekiel Emanuel to discuss his new book, “Eat Your Ice Cream.”
More than a quarter of the agricultural workforce purchases health insurance through the individual marketplace, a much larger share than the overall percentage of U.S. adults. After a tough year for farmers, the loss of enhanced ACA subsidies is putting health insurance out of reach for many.
Affordable health care is our love language. We want to see your most clever, heartfelt, or hilarious tributes to the policies that shape health care. And we've sweetened the deal with prizes.
Measles is at a 30-year high in the U.S., but technicalities may stave off the loss of the nation’s measles elimination status.
The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With more expensive treatments on the horizon, the program — created by the Biden administration and continued under President Trump — could help Medicaid save money and treat more patients.
